Similar articles

• Generic drugs battle moves from South Africa to Kenya.

  Siringi S. Siringi S. Lancet. 2001 May 19;357(9268):1600. doi: 10.1016/S0140-6736(00)04794-2. Lancet. 2001. PMID: 11377665 No abstract available.
• Physicians say generic AIDS drugs don't threaten R&D.

  [No authors listed] [No authors listed] AIDS Policy Law. 2002 Mar 29;17(6):4. AIDS Policy Law. 2002. PMID: 12004757 No abstract available.
• HIV/AIDS: Latin America & Caribbean. Brazil: ten years after.

  Cohen J. Cohen J. Science. 2006 Jul 28;313(5786):484-7. doi: 10.1126/science.313.5786.484b. Science. 2006. PMID: 16873654 No abstract available.
• Access to essential medications for HIV/AIDS in South Africa.

  Andrews S. Andrews S. S Afr Med J. 2001 May;91(5):384-7. S Afr Med J. 2001. PMID: 11455797 Review. No abstract available.
• TRIPS post-2005 and access to new antiretroviral treatments in southern countries: issues and challenges.

  Orsi F, D'Almeida C, Hasenclever L, Camara M, Tigre P, Coriat B. Orsi F, et al. AIDS. 2007 Oct 1;21(15):1997-2003. doi: 10.1097/QAD.0b013e328273bbe4. AIDS. 2007. PMID: 17885289 Review. No abstract available.